Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphism and smoking in bladder carcinogenesis.

British journal of urology - 1 May 1996

Chinegwundoh F I, Kaisary A V

Abstract excerpt

OBJECTIVE: To study the relationship between smoking, a cytochrome P-450 gene polymorphism and the development of bladder cancer. PATIENTS AND METHODS: The study comprised 126 patients with a diagnosis of bladder cancer from whom a full history was obtained. Genomic DNA was extracted from blood sampled from each patient and genotyping of the CYP2D6 locus, the gene responsible for debrisoquine hydroxylase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Polymorphism, Genetic

Share to Smoking

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 8689108
DOI: 10.1046/j.1464-410x.1996.09748.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphism and smoking in bladder carcinogenesis.PMID 8689108Read ↗

Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India.Semantic proximity Read ↗

CYP2D6 genotype and the incidence of anal and vulvar cancer.Semantic proximity Read ↗

Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity.Semantic proximity Read ↗

Analysis of variants in DNA damage signalling genes in bladder cancer.Semantic proximity Read ↗

Genetic polymorphism of CYP2D6 and lung cancer risk.Semantic proximity Read ↗

Genetic Polymorphisms of CYP2A6 in a Case-Control Study on Bladder Cancer in Japanese Smokers.Semantic proximity Read ↗

The procarcinogen hypothesis for bladder cancer: activities of individual drug metabolizing enzymes as risk factors.Semantic proximity Read ↗

CYP2D6 genotype and lung cancer risk according to histologic type and tobacco exposure.Semantic proximity Read ↗

Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians.Semantic proximity Read ↗

CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour.Semantic proximity Read ↗

Debrisoquin oxidation genotype and susceptibility to lung cancer.Semantic proximity Read ↗

Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.